Literature DB >> 30108989

Effect of N-1 arylation of monastrol on kinesin Eg5 inhibition in glioma cell lines.

Itamar Luís Gonçalves1, Liliana Rockenbach1, Gustavo Machado das Neves1, Gabriela Göethel2, Fabiana Nascimento1, Luciano Porto Kagami1, Fabrício Figueiró3, Gabriel Oliveira de Azambuja1, Amanda de Fraga Dias3, Andressa Amaro3, Lauro Mera de Souza4, Ivan da Rocha Pitta5, Daiana Silva Avila6, Daniel Fábio Kawano7, Solange Cristina Garcia2, Ana Maria Oliveira Battastini3, Vera Lucia Eifler-Lima1.   

Abstract

An original and focused library of two sets of dihydropyrimidin-2-thiones (DHPMs) substituted with N-1 aryl groups derived from monastrol was designed and synthesized in order to discover a more effective Eg5 ligand than the template. Based on molecular docking studies, four ligands were selected to perform pharmacological investigations against two glioma cell lines. The results led to the discovery of two original compounds, called 20h and 20e, with an anti-proliferative effects, achieving IC50 values of about half that of the IC50 of monastrol in both cell lines. As with monastrol, flow cytometry analyses showed that the 20e and 20h compounds induced cell cycle arrest in the G2/M phase, and immunocytochemistry essays revealed the formation of monopolar spindles due to Eg5 inhibition without any toxicity to Caenorhabditis elegans.

Entities:  

Year:  2018        PMID: 30108989      PMCID: PMC6072436          DOI: 10.1039/c8md00095f

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  45 in total

1.  Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen.

Authors:  T U Mayer; T M Kapoor; S J Haggarty; R W King; S L Schreiber; T J Mitchison
Journal:  Science       Date:  1999-10-29       Impact factor: 47.728

2.  Development and biological evaluation of potent and specific inhibitors of mitotic Kinesin Eg5.

Authors:  Michael Gartner; Nils Sunder-Plassmann; Jeanette Seiler; Mathias Utz; Isabelle Vernos; Thomas Surrey; Athanassios Giannis
Journal:  Chembiochem       Date:  2005-07       Impact factor: 3.164

Review 3.  Kinesin motor proteins as targets for cancer therapy.

Authors:  Dennis Huszar; Maria-Elena Theoclitou; Jeffrey Skolnik; Ronald Herbst
Journal:  Cancer Metastasis Rev       Date:  2009-06       Impact factor: 9.264

Review 4.  Biological activity of dihydropyrimidinone (DHPM) derivatives: A systematic review.

Authors:  Larizza Hellen Santana Matos; Flávia Teixeira Masson; Luiz Alberto Simeoni; Mauricio Homem-de-Mello
Journal:  Eur J Med Chem       Date:  2017-10-31       Impact factor: 6.514

Review 5.  Privileged scaffolds for library design and drug discovery.

Authors:  Matthew E Welsch; Scott A Snyder; Brent R Stockwell
Journal:  Curr Opin Chem Biol       Date:  2010-03-18       Impact factor: 8.822

6.  Insights into the differential toxicological and antioxidant effects of 4-phenylchalcogenil-7-chloroquinolines in Caenorhabditis elegans.

Authors:  Willian G Salgueiro; Bruna S Goldani; Tanara V Peres; Antonio Miranda-Vizuete; Michael Aschner; João Batista Teixeira da Rocha; Diego Alves; Daiana S Ávila
Journal:  Free Radic Biol Med       Date:  2017-05-30       Impact factor: 7.376

7.  Synthesis and evaluation of dihydropyrimidinone-derived selenoesters as multi-targeted directed compounds against Alzheimer's disease.

Authors:  Flavio A R Barbosa; Rômulo F S Canto; Sumbal Saba; Jamal Rafique; Antonio L Braga
Journal:  Bioorg Med Chem       Date:  2016-09-13       Impact factor: 3.641

8.  Overexpression of Eg5 correlates with high grade astrocytic neoplasm.

Authors:  Liqiong Liu; Xichun Liu; Marcus Mare; Aaron S Dumont; Haitao Zhang; Dong Yan; Zhenggang Xiong
Journal:  J Neurooncol       Date:  2015-10-11       Impact factor: 4.130

9.  The Molecular Biology Toolkit (MBT): a modular platform for developing molecular visualization applications.

Authors:  John L Moreland; Apostol Gramada; Oleksandr V Buzko; Qing Zhang; Philip E Bourne
Journal:  BMC Bioinformatics       Date:  2005-02-06       Impact factor: 3.169

Review 10.  Glioblastoma Stem-Like Cells: Characteristics, Microenvironment, and Therapy.

Authors:  Yang Yi; I-Yun Hsieh; Xiaojia Huang; Jie Li; Wei Zhao
Journal:  Front Pharmacol       Date:  2016-12-07       Impact factor: 5.810

View more
  1 in total

1.  Novel coumarins active against Trypanosoma cruzi and toxicity assessment using the animal model Caenorhabditis elegans.

Authors:  Fabiana Gomes Nascimento Soares; Gabriela Göethel; Luciano Porto Kagami; Gustavo Machado das Neves; Elisa Sauer; Estefania Birriel; Javier Varela; Itamar Luís Gonçalves; Gilsane Von Poser; Mercedes González; Daniel Fábio Kawano; Fávero Reisdorfer Paula; Eduardo Borges de Melo; Solange Cristina Garcia; Hugo Cerecetto; Vera Lucia Eifler-Lima
Journal:  BMC Pharmacol Toxicol       Date:  2019-12-19       Impact factor: 2.483

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.